Denali Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.

About DNLI

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. 

CEO
Ryan J. Watts
CEORyan J. Watts
Employees
422
Employees422
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2013
Founded2013
Employees
422
Employees422

DNLI Key Statistics

Market cap
2.08B
Market cap2.08B
Price-Earnings ratio
-5.36
Price-Earnings ratio-5.36
Dividend yield
—
Dividend yield—
Average volume
1.44M
Average volume1.44M
High today
$14.42
High today$14.42
Low today
$13.36
Low today$13.36
Open price
$13.95
Open price$13.95
Volume
1.79M
Volume1.79M
52 Week high
$33.33
52 Week high$33.33
52 Week low
$10.57
52 Week low$10.57

Analyst ratings

100%

of 19 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own DNLI. This list is generated using Robinhood data, and it’s not a recommendation.
Pfizer
CRISPR
Taiwan Semiconductor Manu…
Moderna
Micron Technology
Block
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.